Bayer introduces pain relief Aleve Direct Therapy

17 July 2016 (Last Updated July 17th, 2016 18:30)

Medical device company Bayer has introduced pain relief device Aleve Direct Therapy in the US.

Medical device company Bayer has introduced pain relief device Aleve Direct Therapy in the US.

Aleve Direct Therapy uses the same transcutaneous electrical nerve stimulation (TENS) technology used by doctors to provide patients with deep penetrating relief at the source of lower back pain.

A non-invasive, drug-free method of controlling pain, TENS  works by delivering stimulating pulses at the site of pain. 

"Aleve Direct Therapy puts controllable TENS technology in consumer hands without having to visit the doctor."

US Medical Affairs consumer health division vice-president Andre Schmidt said: "Aleve Direct Therapy puts controllable TENS technology in consumer hands without having to visit the doctor.

“It provides high-intensity power and its wireless remote control makes it easy to adjust the power of intensity to fit the user's needs.”

It is indicated for temporary relief of pain associated with sore and aching muscles in the lower back due to strain from exercise or normal household and work activities.

Regulated as a Class II medical device, Aleve Direct Therapy was cleared by the US Food and Drug Administration.

Its patented waveform technology can offer penetrating relief by blocking the body's pain signals and by releasing endorphins in the areas of pain.